Skip to main content
VCbacked
Log inGet Started

Entos Pharmaceuticals

Edmonton, Canada

Entos Pharmaceuticals is a clinical-stage biotech company developing genetic medicines with its Fusogenix PLV drug delivery platform.

$1.0M raised
May 2025
Venture - Series Unknown
BiotechnologyHealth CarePharmaceutical

Top Investors

California Institute for Regenerative MedicineCureDuchenne Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Entos Pharmaceuticals

How much funding has Entos Pharmaceuticals raised?
Entos Pharmaceuticals has raised $1.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2025.
Who are Entos Pharmaceuticals's investors?
Entos Pharmaceuticals's investors include California Institute for Regenerative Medicine, CureDuchenne Ventures.
Where is Entos Pharmaceuticals headquartered?
Entos Pharmaceuticals is headquartered in Edmonton, Canada.
What does Entos Pharmaceuticals do?
Entos Pharmaceuticals is a clinical-stage biotech company developing genetic medicines with its Fusogenix PLV drug delivery platform.
What stage is Entos Pharmaceuticals at?
Entos Pharmaceuticals is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Entos Pharmaceuticals — Funding & Investors." VCBacked, May 22, 2025, https://www.vcbacked.co/company/entos-pharmaceuticals. Accessed June 3, 2026.
APA
VCBacked. (2025). Entos Pharmaceuticals — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/entos-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Entos Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/entos-pharmaceuticals |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong